Related Experiment Video

Updated: Aug 9, 2025

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
08:28

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro

Published on: February 15, 2022

3.8K

Thymosin ß4 and MRTF-A mitigate vessel regression despite cardiovascular risk factors

Christian Kupatt1, Tilman Ziegler2, Andrea Bähr2

  • 1Medizinische Klinik und Poliklinik I, Klinikum rechts der Isar, 81675 Munich, Germany; Deutsches Zentrum für Herz-Kreislaufforschung (German Centre of Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.

International Immunopharmacology
|February 22, 2023
PubMed

Insights

Cardiovascular risk factors cause capillary rarefaction, a condition untreated by current therapies. Thymosin ß4 (Tß4) shows potential to reverse this microvascular damage by addressing inflammation and stabilizing vessels.

Area of Science:

  • Cardiovascular Medicine
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Coronary and peripheral artery disease (CAD/PAD) treatments target large vessels, neglecting the microcirculation.
  • Cardiovascular risk factors induce microcirculatory rarefaction, a significant unmet therapeutic need.
  • Inflammation and vessel destabilization are key barriers to reversing capillary rarefaction.

Approach:

  • Review of current knowledge on capillary rarefaction mechanisms.
  • Exploration of angiogenic gene therapy potential for microvascular repair.
  • Discussion of Thymosin ß4 (Tß4) and its downstream MRTF-A signaling pathway.

Key Points:

  • Cardiovascular risk factors contribute to both macrovascular and microvascular disease.
  • Microcirculatory rarefaction is a critical but overlooked aspect of cardiovascular pathology.
  • Thymosin ß4 (Tß4) and MRTF-A signaling offer a promising therapeutic avenue for microvascular regeneration.

Conclusions:

  • Targeting microcirculatory rarefaction is essential for comprehensive cardiovascular disease management.
  • Thymosin ß4 (Tß4) presents a potential therapeutic strategy to restore microvascular function.
  • Addressing inflammation is crucial for the success of angiogenic therapies in cardiovascular disease.

Keywords:
AAVAngiogenesisArteriogenesisCapillary rarefactionGene therapy

More Related Videos

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.4K
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

19.6K

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16